Conference 2019, Maastricht

In November 2019 we organized the first international conference on MDC1A, held in Maastricht, The Netherlands. On this page you'll find information about the lectures that where given by some of the experts who attended the event.

The speakers

The experts on MDC1A / Lama2 CMD

The clinical spectrum of MDC1A

By R. Foley

Investigator at the Neuromuscular and Neurogenic Disorders of Childhood Section - National Institutes of Health, USA. Dr. Reghan Foley is specialised in pediatric neuromuscular diseases.

Clinical management of MDC1A

By H. Sawnani

H. Sawnani, M.D. is a pediatric pulmonologist at the Cincinnati Children’s Hospital in the USA. His interest lies with pulmonary care for patients with muscular dystrophy.

Genotype-phenotype correlations in MDC1A and CMD

By A. Sarkozy

Honorary Senior Lecturer and Consultant in Neuromuscular Diseases at the Dubowitz Neuromuscular Centre at the UCL Institute of Child Health and Great Ormond Street Hospital for Children, London, UK

Therapeutic strategies for MDC1A

By M. Durbeej

Head of the Department of Experimental Medical Science and Professor of Muscle Biology at Lund University, Sweden

Gene therapy for MDC1A

By D. Kemaladewi

D. Kemaladewi is an Assistant Professor at the University of Pittsburgh, USA. Her research focusses on underlying molecular mechanisms of muscular dystrophies.

Stem cell therapy in congenital MD

By G. Cossu

Constance Thornley Professor of Regenerative Medicine, position in Extended Committee and clinical expert and cell therapy.